A comparative study of a cohort of 33 MDS, a condition with a known prominent inflammasome, patients with healthy controls found that in MDS CD8+ T-cells exhibited decreased levels of CCR7 and a concomitant upregulation of CCR3, CCR5, or CX3CR1 (194). This evidence concerns the gene CCR7 and myelodysplastic syndrome.